- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04613466
The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease
November 10, 2020 updated by: Hayam Fathy Nasr, Assiut University
The Prevelance of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease
Bronchopulmonary manifestations signs and symptoms are variable extraintestinal manifestations of IBD.
Study Overview
Status
Unknown
Detailed Description
Several cases like bronchiactsis, bronchitis, tracheobronchitis and broncholitis.
None of this complications are specific for either crohns or ulcerative , however the majority of cases are related to ulcerative colitis.
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients diagnosed IBD either male or female age 18 to 60 years
Description
Inclusion Criteria:All patients diagnosed ulcerative colitis and crohns disaese on conventional treatment and biological treatment -
Exclusion Criteria:no exclusion criteria
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The presence of pulmonary manifestations in IBD patients
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2020
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
June 1, 2022
Study Registration Dates
First Submitted
October 28, 2020
First Submitted That Met QC Criteria
October 28, 2020
First Posted (Actual)
November 3, 2020
Study Record Updates
Last Update Posted (Actual)
November 13, 2020
Last Update Submitted That Met QC Criteria
November 10, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Gateroentrolgy unit
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease
-
Technical University of MunichCompletedQuality of Life in Patients With Inflammatory Bowel DiseaseGermany
-
Assiut UniversityUnknownHepatobilliary Manifestations in Inflammatory Bowel Disease Patients
-
Chun PanUnknownEvaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.China
-
CerbaXpertRecruitingEvaluate the Physiological Stability of NIS4 Biomarker Between the Fed and Fasting State in Patients With the Target Condition (NAFLD)France
-
Marmara UniversitySaglik Bilimleri UniversitesiCompletedOral Health in Children With Inflammatory Bowel DiseaseTurkey
-
Sun Yat-sen UniversityCompletedEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical TreatmentChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingTo Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
-
Zhongshan Bo Ai HospitalCompletedThe Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group; | At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether; | 534... and other conditionsChina
-
Fondation Ophtalmologique Adolphe de RothschildCompletedEstimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2France
-
AstraZenecaCompletedThe Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPIKorea, Republic of